What SUV Value — Indicates Cancer?

No single SUV number confirms cancer, regardless of how high it is. The only way to confirm cancer is with a biopsy — a physical sample examined by a pathologist under a microscope. A very high reading may increase the radiologist's level of suspicion and lead to further investigation, including biopsy, but it is evidence to be weighed alongside everything else. Your oncologist will explain what the finding means for the next step in your care.

The figure entered common use from early research into solitary pulmonary nodules — single spots on the lung — where it had some usefulness in a narrow context. It has since been repeated so widely that it appears in reports and conversations as though it applies universally. It does not. Even in the original lung nodule research it came from, it was a statistical observation in a specific patient population, not a biological threshold. If 2.5 appears in your report, ask your oncologist what it means in your specific situation rather than treating it as a decision point.

Yes. Infection, inflammation, post-surgical healing, and autoimmune conditions can all produce elevated readings. Active tuberculosis and sarcoidosis in particular are well documented in nuclear medicine literature to produce readings that overlap with what would be seen in malignant disease — a limitation especially relevant in India, where TB is common. This overlap is one of the central reasons a radiologist always considers clinical history and CT appearances before drawing any conclusion from the SUV number alone.

Yes. Some cancer types — including certain low-grade lymphomas, well-differentiated neuroendocrine tumours, and some mucinous carcinomas — can be active while showing modest SUV readings. A number within a range that might seem unremarkable does not confirm that an area is clear, particularly for these tumour types. This is another reason a single fixed threshold does not work across all cancers, and why your oncologist considers your specific diagnosis when interpreting the result.

A rise between two scans is worth discussing with your oncologist, but it does not automatically mean your cancer has worsened. Scan conditions, blood glucose levels at the time of injection, the interval between injection and imaging, and small differences in how the region is measured can all influence the number. Your oncologist compares the two scans properly — looking at the same lesions under consistent conditions and in the context of your symptoms and other results — before drawing any conclusion about disease behaviour.

Ask what the finding means in your specific situation, not what the number means in isolation. Useful questions are: which areas showed elevated uptake, whether those areas are new or have changed from a previous scan, what the clinical significance is given your cancer type and stage, and what the recommended next step is. It is entirely reasonable to ask for the report to be explained in plain language, and to ask for the key findings in writing so you have them to refer back to.